ICCM Icecure Medical
Company Analysis
Latest News
🔴 ICCM Falls 26% to $6.91 Amid Profit-Taking, Regains Nasdaq Compliance
ICCM is trading 26% down today at $6.91, primarily due to investors locking in profits after a massive multi-day rally. This occurs despite IceCure Medical...
🔴 ICCM makes sharp 13.3% drop
ICCM is trading at $8.06, down 13.3% versus the comparison close of $9.30 during pre-market. This is a price-movement alert; no separate company-specific...
🔴 ICCM is trading 5.7% down today on profit-taking after a sharp multi-day rally
ICCM is trading at $8.77 (down 5.7%) as the stock undergoes a pre-market pullback following a significant rally driven by ProSense commercial adoption and...
🟢 ICCM surges over 43% today, extending momentum from recent commercial adoption and funding news
• ICCM is trading significantly up today, reaching $8.76 after an over 43% surge in after-hours trading. • This surge extends recent momentum driven by the...
🟢 ICCM is trading 11.6% up today on continued momentum from ProSense adoption and a premium private placement
ICCM is trading 11.6% up now at $6.83, extending a sharp multi-day rally following a June commercial update highlighting rapid U.S. ProSense adoption and a...
🟢 ICCM is trading 11.8% up today on rapid U.S. ProSense adoption and install base growth and $5.5M private placement
ICCM is trading 11.8% up today at $6.63 following a late-June commercial update highlighting rapid U.S. adoption of its ProSense system and a significant...
🟢 ICCM is trading 12.8% up today as FDA-backed adoption news fuels extended rally
ICCM is trading 12.8% up at $6.09 in pre-market, extending a sharp rally following a June 17 announcement highlighting FDA-backed adoption of its...
Icecure Medical Triples in a Week on FDA-Backed Tumor-Freezing Adoption — But Can $3.4 Million in Annual Sales Justify a $18 Million Valuation?
Shares of Icecure Medical rocketed from $2.13 to $6.45 in four trading sessions — a roughly 200% surge — after a triple-barreled announcement on June 17...
🟢 Icecure Medical is trading 19.4% up today on ProSense adoption and premium private placement news
Icecure Medical is trading at $6.45 (19.4%) up today, extending a sharp rally driven by recent FDA-related adoption news and strategic financing. • The move...